- Entry
- $1.60
- Final
- $1.81 +13.1%
- Target
- —
- Score
- +1.00
I rarely see any posts on this one. It feels like it had been deeply oversold a month ago, I'm in but I'm wondering if I'm missing something? Quick AI summary of what they do : "ProQR Therapeutics is a clinical-stage biotech developing Axiomer™, a proprietary RNA base-editing platform. Their lead product, AX-0810, aims to treat cholestatic liver diseases by editing NTCP RNA to modulate protein function. " as for the strong catalysts: - AX-0810 Data: Target engagement readout in …
— ORIGINAL POST ·
Am I reading this wrong for PRQR?
· r/pennystocks
· May 12, 2026